Rongbin Lv
Overview
Explore the profile of Rongbin Lv including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
44
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Li M, Liu J, Lv R, Liu F, Wang G, Wang J, et al.
Nucl Med Commun
. 2025 Jan;
46(4):347-355.
PMID: 39829250
Objectives: Parkinson's disease (PD) is a neurodegenerative disorder with distinct metabolic alterations in the brain, which are detectable via 18 F-FDG PET. This study aims to delineate glucose metabolism patterns...
2.
Tian Q, Li J, Lv R, Zhou G, Liu X, Wang Y, et al.
Brain Res
. 2024 Oct;
1847:149292.
PMID: 39461665
Background: Ischemic stroke has become one of the leading causes of death and disability worldwide in individuals aged 60 and above. However, currently available drugs show limited efficacy. Therefore, research...
3.
Li M, Liu J, Liu F, Lv R, Bai H, Liu S
World J Nucl Med
. 2024 Apr;
23(1):33-42.
PMID: 38595841
The purpose of this study was to evaluate the prognostic significance of corrected baseline metabolic parameters in fluorodeoxyglucose positron emission tomography imaging ( F-FDG PET/CT) for 3-year progression-free survival (PFS)...
4.
Wang Q, Jiang Y, Guo R, Lv R, Liu T, Wei H, et al.
Biomed Pharmacother
. 2022 Jan;
146:112625.
PMID: 35031233
No abstract available.
5.
Liu C, Wang L, He X, Xu Y, Lu D, Li P, et al.
J Magn Reson Imaging
. 2018 Jan;
48(2):382-388.
PMID: 29319916
Background: Pancreatic carcinoma is a common cause of cancer deaths worldwide. Biopsy is often required for the initial diagnosis of pancreatic masses. Biopsy can be performed endoscopically or percutaneously with...
6.
Wang Q, Jiang Y, Guo R, Lv R, Liu T, Wei H, et al.
Biomed Pharmacother
. 2017 Jun;
92:451-458.
PMID: 28570979
This article has been retracted: please see Elsevier Policy on Article Withdrawal (https://www.elsevier.com/about/our-business/policies/article-withdrawal).
This article has been retracted at the request of the Editor-in-Chief.
Panels from Figures 1B and 3C...
7.
Xu S, Liu Y, Li Y, Deng Y, Yuan J, Lv R, et al.
Psychiatry Res Neuroimaging
. 2017 Apr;
263:121-126.
PMID: 28376406
This study was to reconfirm the reduced dopamine transporter (DAT) availability in heroin-dependent subjects and validate the use of 2β-carbomethoxy-3β-(4-chlorophenyl)-8-(2-fluoroethyl)-nortropane (F-FECNT) as a PET radiotracer to assess the changes of...
8.
Xu S, Liu Y, Li Y, Deng Y, Huang Y, Yuan J, et al.
Psychopharmacology (Berl)
. 2015 Jun;
232(18):3391-401.
PMID: 26096461
Rationale: Chronic exposure to heroin results in decreased dopamine transporter levels. Jitai tablets, a traditional Chinese medicine, have been effective at increasing striatal dopamine transporter availability after 6 months of...
9.
Yuan J, Lv R, Brasic J, Han M, Liu X, Wang Y, et al.
Psychiatry Res
. 2013 Dec;
221(1):92-6.
PMID: 24314908
Single-photon emission-computed tomography (SPECT) after the administration of (99m)Tc-TRODAT-1 was performed on healthy subjects and subjects with methamphetamine (METH)dependence at time 1 (T1) after 24-48 h of abstinence, time 2...
10.
Liu Y, Han M, Liu X, Deng Y, Li Y, Yuan J, et al.
Psychopharmacology (Berl)
. 2013 May;
230(2):235-44.
PMID: 23715641
Rationale: Previous imaging studies have indicated that the levels of the dopamine transporter (DAT) are reduced in the brains of heroin users. However, whether these changes can be reversed by...